At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Cambridge based Director operating in the Artificial Intelligence space. If you think a Director is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Enrique Munoz de Cote
Director of MAS Science of Secondmind
Enrique is an associate professor of computer science with more than 50 academic papers published in top-tier journals and conferences in AI, including a book on multi agent learning. His interests lie in the intersection between machine learning, AI and economic theory. He has studied in Mexico, the USA, Italy and the UK and speaks three languages. He is responsible for heading the multi-agent team. He is a mélomane and terrible guitar player who grew up listening to rock. He is not wholly convinced that combing his curly hair is the way to go.
Follow Enrique Munoz de Cote:
About Geckomatics, Geckomatics, Secondmind: Machine learning for automotive innovators
_______
James Hensman
Director of Research of Secondmind
James is a senior machine learning scientist with more than fifty peer-reviewed publications. Having worked at multiple universities he now lives in Ely with his family. He leads the company’s research in the area of probabilistic models. James loves the great British summer, and will happily barbecue in the rain. He is a terrible beer snob.
Follow James Hensman:
About Secondmind: Machine learning for automotive innovators
Erkko Uusitalo
Director, AI for Finance of Secondmind
Erkko is a financial markets expert with 20 years experience in trading & fund management. He is from Finland and that is where he mostly works from. He brings practical knowledge to the financial domain. He claims to remember pi to the 1.000th decimal – he just does not know what to do with that information!
Follow Erkko Uusitalo:
About Secondmind: Machine learning for automotive innovators
Karthik Tadinada
Director of Data Science of Featurespace
Karthik is responsible for working with Featurespace’s Financial Services and Insurance clients for analysis and modelling of their data. Karthik studied with Professor Fitzgerald (Featurespace founder) at Cambridge University Engineering Department’s Signal Processing Group. He has a first-class honours degree in Engineering and a PhD in Electrical Engineering, both from the University of Cambridge. Karthik’s previous roles include a stint as Junior Consultant at the Boston Consulting Group, where his work included helping FTSE 100 companies in the financial, IT and mining sectors.
Follow Karthik Tadinada:
About Featurespace: Featurespace provides an adaptive behavioral analytics technology and automated deep behavioral networks for risk management.
David Holden-White
Co-Founder & Managing Director of techspert.io
David Holden-White is the Co-Founder at techspert.io.
Follow David Holden-White:
About techspert.io: techspert.io is an AI-driven technology for identifying and sourcing specialist expertise, globally.
Graham Mills
Co-Founder & Managing Director of techspert.io
Graham Mills is the Co-Founder at techspert.io.
Follow Graham Mills:
About techspert.io: techspert.io is an AI-driven technology for identifying and sourcing specialist expertise, globally.
Daniel Cowell
Director of techspert.io
Follow Daniel Cowell:
About : techspert.io is an AI-driven technology for identifying and sourcing specialist expertise, globally.
Kathy Hinderhofer
Director of Micronotes
Follow Kathy Hinderhofer:
About : Micronotes is an AI-enabled cloud-based marketing automation company leverging automated interviews to solve the digital engagement problem.
David Brown
Co-Founder and Chairman of the Board of Directors of Healx
David Brown has 40 years experience in the pharmaceutical / biotechnology industry both in research and in senior executive roles. He served with 4 of the top 10 pharmaceutical companies: Zeneca, Pfizer, GlaxoWellcome, and Hoffman La-Roche. Whilst at Pfizer he was named co-inventor on the patent for Viagra, and for 8 years he led the team that invented and developed Viagra through to proof of clinical efficacy in male impotence. The drug is also marketed for treatment of pulmonary hypertension under the trade name Revatio. He also had a pivotal role in the discovery of Relpax, a treatment for migraine. Together these drugs have achieved sales of over $30 billion. While at Roche in Switzerland, he was a Director of the company and, as Global Head of Drug Discovery, he had responsibility for productivity of over 2000 scientists at Roche’s five research sites in the USA, Europe and Asia. David subsequently co-founded antibody company Crescendo Biologics and serves on the boards of Healx Ltd (Chair), ProFactor Pharma Ltd (Chair) and Babraham Institute Enterprise Ltd (Chair). He is a Trustee (Director) of two charities, Antibiotic Research UK, dedicated to solving the looming problem of antibiotic resistance; and Friends of Manjushree Vidyapith School and Orphanage, a charity he co-founded in 2005 to help destitute orphans in South Tibet.
Follow David Brown:
About Healx: Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
Ian Roberts
Director of Therapeutic Technology of Healx
As senior investigator at the MRC Cancer Cell Unit, Cambridge, Ian lead the development of molecular cytogenetic and genomics approaches for the discovery of disease genes in small round blue cell tumours, and cervical carcinoma. During this time Ian developed algorithms for copy number imbalance analysis and integration with expression data using array based techniques. Following a move to industry, as Head of Informatics at Population Genetics Technologies Ltd Ian lead the development of Next Generation DNA Sequencing (NGS) variant discovery pipelines. Ian continued to develop NGS based variant discovery workflows as Senior Bioinformatician at 14M Genomics, before joining Healx in 2016.
Follow Ian Roberts:
About Healx: Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
Huw Price
Academic Director and Bertrand Russell Professor of Philosophy of Leverhulme Centre for the Future of Intelligence
Huw Price is a Co-Founder at Centre for Study of Existential Risk.
Follow Huw Price:
About Centre for Study of Existential Risk, Leverhulme Centre for the Future of Intelligence: Leverhulme is a research centre exploring the opportunities and challenges to humanity from the development of artificial intelligence.